Amit Mahipal

This study is for people with advanced liver cancer who are already receiving durvalumab after initial treatment with tremelimumab and durvalumab. Researchers want to see if adding an experimental oral drug called zanzalintinib to the ongoing durvalumab treatment helps people liv…